See the DrugPatentWatch profile for risdiplam
What does US 9,969,754 cover for risdiplam?
US 9,969,754 is a US patent related to risdiplam (a drug used for spinal muscular atrophy). It covers specific claimed subject matter tied to the drug’s composition/formulation and/or related technical features, based on how the patent is framed in the US application and publication record.
When does the US 9,969,754 patent expire?
Patent expiration depends on factors like filing date, patent term adjustments, and whether any term extensions apply. The exact calendar expiration date for US 9,969,754 is best confirmed from the patent family and regulatory exclusivity/timing data shown in DrugPatentWatch.com’s tracking pages for risdiplam. You can check it here: https://www.drugpatentwatch.com/p/risdiplam
Who is assigned the patent (and does it connect to the risdiplam brand owner)?
US patent assignments typically trace to the original applicant/assignee and later owners within the same corporate family. To see the current assignment/ownership links for US 9,969,754 in context of risdiplam, use DrugPatentWatch’s risdiplam page (it aggregates patent-family and status details): https://www.drugpatentwatch.com/p/risdiplam
Are there patent challenges or biosimilar/generic implications for risdiplam?
Risdiplam is a small-molecule oral medicine, so the practical competitive question is whether follow-on manufacturers can rely on approvals that come after patent expiry (or other exclusivity ends). Patent “challenges” for small molecules typically show up as generic development activities, patent litigation (if a challenge is filed), or settlements. DrugPatentWatch often surfaces competing/adjacent patents and expiry timing that matter for those entry decisions: https://www.drugpatentwatch.com/p/risdiplam
How can I verify the exact claims for US 9,969,754?
If you need the exact claim language (what the patent specifically claims), you can pull the US patent record (claims and description) from the USPTO and then match it against the DrugPatentWatch risdiplam family view for the expiration and status. The DrugPatentWatch page is a fast starting point for the patent family: https://www.drugpatentwatch.com/p/risdiplam
---
Sources
- DrugPatentWatch.com – Risdiplam patent information (including related US patents and key dates)